Will JHX generate free cash flow exceeding $500M in FY2027 (April 2026-March 2027)?

FY26 FCF is ~$200M, so reaching $500M in FY27 requires a $300M improvement. The bridge: lower integration costs ($50-100M), lower CapEx ($50-75M decline from $400M), plant closure savings ($25M), and organic EBITDA improvement ($50-100M if housing recovers). This sums to $175-300M improvement, reaching $375-500M. The $500M threshold is at the very top of the improvement range, requiring everything to go right. Housing recovery is the key variable and remains uncertain.

The FCF bridge from $200M to $500M is plausible but requires multiple tailwinds to converge. Critically, interest expense (~$290M) is a permanent drag that won't decline meaningfully in FY27 unless significant debt is repaid. Working capital needs could increase if revenue recovers (inventory build for growth). The $500M pre-AZEK standalone target was achievable because JHX had near-zero debt and lower CapEx requirements. The combined company faces a structurally different cash flow profile.

Management projects FY27 'return to organic revenue growth and EBITDA margin expansion,' and declining integration/deal costs should release $100-150M. If EBITDA reaches $1.35-1.4B (up from $1.25B) and CapEx drops to $325-350M, operating cash flow could reach $900-950M, yielding FCF of $550-625M. But this requires a fairly optimistic housing scenario. If housing stays flat, EBITDA stays around $1.25-1.3B and FCF likely reaches $350-450M — below the threshold.

The pre-AZEK standalone FCF target was $500M with near-zero debt. Now the company has $290M annual interest. So comparable FCF generation would require operating cash flow of $790M — essentially $290M more than before. Even with AZEK's additional EBITDA contribution, the interest burden is a structural shift. Integration cost savings of $100-150M help but don't fully bridge the gap. I assess a base case FY27 FCF of $350-400M, with $500M requiring a meaningful housing recovery.

FY26 FCF YTD 9 months is $261M vs full-year guide of 'at least $200M' — suggesting Q4 may have negative FCF or the YTD run rate is front-loaded. If annualized 9-month run rate is ~$348M, that's a better starting point. With $50-100M integration cost savings and $50M CapEx decline in FY27, FCF could reach $450-500M even without housing recovery. The $500M threshold is achievable but not the base case.

Several structural headwinds work against $500M FCF in FY27: (1) $290M interest is fixed for FY27; (2) CapEx at 6-7% of ~$5B sales = $300-350M; (3) working capital needs for a growing business; (4) remaining integration costs. Even with EBITDA at $1.3B, after $290M interest and $325M CapEx, FCF is ~$685M minus taxes and working capital — maybe $400-500M. The lower end is more likely given uncertain housing.

FCF improvement from $200M to $500M requires $300M swing. Integration cost savings, lower CapEx, and plant closures provide $125-175M. Remaining $125-175M must come from EBITDA growth, which depends on housing recovery. Achievable but not base case.

The $500M threshold is aspirational for FY27. Pre-AZEK JHX targeted $500M with no debt service. Post-AZEK with $290M interest, matching that level requires fundamentally higher operating cash flow. More realistic FY27 FCF is $350-450M range. Probability below 30%.

If housing recovers modestly in H2 FY27 and synergies deliver incremental EBITDA, $500M+ FCF is achievable. Management clearly expects FY27 to be a step-change year. The FY26 YTD FCF of $261M in 9 months is better than the annual guide suggests. Assigning slightly higher probability for the tail scenario where multiple tailwinds align.